Oral Administration of Oyster Peptide Prevents Bone Loss in Ovariectomized Mice
Osteoporosis is a disordered metabolic disease occurred congenitally or secondary. Although peptide agents have been approved to prevent osteoporosis administrated through subcutaneous injection, rare reports focused on peptide oral administration for preventive purpose. An eight peptide, P-CG-01 (Y...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-08-01
|
| Series: | eFood |
| Subjects: | |
| Online Access: | https://www.atlantis-press.com/article/125943539/view |